Clinical utility of serum biomarkers for hepatocellular carcinoma

Biomark Med. 2021 Feb;15(3):151-155. doi: 10.2217/bmm-2020-0474. Epub 2021 Jan 20.
No abstract available

Keywords: AFP; AFP-L3; PIVKA-II; biomarker; diagnosis; disease modeling; hepatocellular carcinoma; individual outcomes; prediction.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor* / blood
  • Carcinoma, Hepatocellular* / blood
  • Carcinoma, Hepatocellular* / diagnosis
  • Humans
  • Liver Neoplasms* / blood
  • Liver Neoplasms* / diagnosis

Substances

  • Biomarkers, Tumor